Skip to main content
logo
20/20 Biolabs, Inc. (AIDX)
NASDAQ: AIDX · Real-Time Price · USD
0.4220
+0.0130 (3.18%)
Sep 29, 2026, 1:49 PM EDT - Market open

20/20 Biolabs Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.18-70.670.560.290.150.19
Debt / EBITDA Ratio
----0.680.57
Debt / FCF Ratio
----0.26-
Net Debt / Equity Ratio
-1.26-17.30-0.63-0.67-0.79-0.30
Net Debt / EBITDA Ratio
0.92-0.100.170.46-3.89-1.01
Net Debt / FCF Ratio
1.42-0.170.360.64-1.331.60
Asset Turnover
0.460.530.350.150.98-
Inventory Turnover
16.1817.6425.8217.8035.58-
Quick Ratio
1.900.501.424.115.873.36
Current Ratio
1.990.601.504.255.973.52
Return on Equity (ROE)
-331.22%-503.12%-191.67%-93.56%26.89%-
Return on Assets (ROA)
-62.37%-53.92%-71.10%-42.79%9.33%-
Return on Capital Employed (ROCE)
-123.20%-199.00%-253.90%-118.80%15.90%24.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-47.91%-2.70%-0.66%49.73%-0.26%-100.78%
SEC Filings: 10-K · 10-Q